{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:11:10Z","timestamp":1779448270975,"version":"3.53.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-026-01485-z","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T10:00:44Z","timestamp":1779444044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Post-neoadjuvant Metabolic Response Assessed by \u00b9\u2078F-FDG PET\/CT Predicts Pathologic Complete Response and Survival in Esophageal Squamous Cell Carcinoma Treated with the CROSS Regimen"],"prefix":"10.1007","volume":"57","author":[{"given":"Saravanan","family":"Moorthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnamurthy","family":"Arvind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pushkala","family":"Surianarayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivedita","family":"P","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manikandan","family":"V","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"1485_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray F, Laversanne M, Sung H, et al., et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2022;74:229\u201363.","journal-title":"Cancer J Clin"},{"key":"1485_CR2","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1055\/s-0041-1726139","volume":"9","author":"A Krishnamurthy","year":"2020","unstructured":"Krishnamurthy A, Behuria SS. Demographic Trends in Carcinoma Esophagus from India. South Asian J Cancer. 2020;9:163\u20137.","journal-title":"South Asian J Cancer"},{"key":"1485_CR3","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P van Hagen","year":"2012","unstructured":"van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074\u201384.","journal-title":"N Engl J Med"},{"key":"1485_CR4","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","volume":"16","author":"J Shapiro","year":"2015","unstructured":"Shapiro J, van Lanschot JJ, Hulshof MC, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16:1090\u20138.","journal-title":"Lancet Oncol"},{"key":"1485_CR5","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1200\/JCO.20.03614","volume":"39","author":"BM Eyck","year":"2021","unstructured":"Eyck BM, van Lanschot JJB, Hulshof MCCM, et al. Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial. J Clin Oncol. 2021;39:1995\u20132004.","journal-title":"J Clin Oncol"},{"key":"1485_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4251\/wjgo.v6.i5.139","volume":"6","author":"OS Al-Taan","year":"2014","unstructured":"Al-Taan OS, Eltweri A, Sharpe D, Rodgers PM, Ubhi SS, Bowrey DJ. Prognostic value of baseline FDG uptake on PET-CT in esophageal carcinoma. World J Gastrointest Oncol. 2014;6:139\u201344.","journal-title":"World J Gastrointest Oncol"},{"issue":"4","key":"1485_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4103\/wjnm.WJNM_114_18","volume":"18","author":"S Singh","year":"2019","unstructured":"Singh S, Bisht N, Sarin A, et al. Predicting radiotherapy-induced tumor regression in esophageal carcinoma using PET-CT. World J Nucl Med. 2019;18(4):361\u20135.","journal-title":"World J Nucl Med"},{"key":"1485_CR8","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3332\/ecancer.2021.1291","volume":"15","author":"T Bhattacharyya","year":"2021","unstructured":"Bhattacharyya T, Arunsingh M, Chakraborty S, et al. CROSS protocol in real world scenario with broader eligibility. Ecancermedicalscience. 2021;15:1291.","journal-title":"Ecancermedicalscience"},{"issue":"2","key":"1485_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s13193-015-0402-3","volume":"6","author":"A Goel","year":"2015","unstructured":"Goel A, Shah SH, Selvakumar VP, et al. Radical esophagectomy after neoadjuvant chemoradiation: Indian experience. Indian J Surg Oncol. 2015;6(2):207\u201312.","journal-title":"Indian J Surg Oncol"},{"key":"1485_CR10","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJ, et al. FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328\u201354.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1485_CR11","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1245\/s10434-009-0862-1","volume":"17","author":"KL Meredith","year":"2010","unstructured":"Meredith KL, Weber JM, Turaga KK, et al. Pathologic response determines survival in esophageal cancer. Ann Surg Oncol. 2010;17:1159\u201367.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"1485_CR12","doi-asserted-by":"publisher","first-page":"7422","DOI":"10.1245\/s10434-023-13643-9","volume":"30","author":"F Gebauer","year":"2023","unstructured":"Gebauer F, Plum PS, Damanakis A, et al. CROSS vs. FLOT in esophageal adenocarcinoma. Ann Surg Oncol. 2023;30(12):7422\u201333.","journal-title":"Ann Surg Oncol"},{"key":"1485_CR13","doi-asserted-by":"publisher","first-page":"646","DOI":"10.4103\/ijc.IJC_452_17","volume":"54","author":"A Krishnamurthy","year":"2017","unstructured":"Krishnamurthy A, Mohanraj N, Radhakrishnan V, et al. Neoadjuvant chemoradiation in esophageal cancer: Indian experience. Indian J Cancer. 2017;54:646\u201351.","journal-title":"Indian J Cancer"},{"key":"1485_CR14","first-page":"290","volume":"14","author":"S Surendran","year":"2024","unstructured":"Surendran S, Midha G, Mathew M, et al. Feasibility of CROSS protocol in Indian ESCC patients. South Asian J Cancer. 2024;14:290\u2013300.","journal-title":"South Asian J Cancer"},{"key":"1485_CR15","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1053\/j.gastro.2017.08.023","volume":"154","author":"CC Abnet","year":"2018","unstructured":"Abnet CC, Arnold M, Wei WQ. Epidemiology of Esophageal Squamous Cell Carcinoma. Gastroenterology. 2018;154:360\u201373.","journal-title":"Gastroenterology"},{"key":"1485_CR16","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.4103\/jfmpc.jfmpc_1111_19","volume":"9","author":"D Choksi","year":"2020","unstructured":"Choksi D, Kolhe KM, Ingle M, et al. Esophageal carcinoma: An epidemiological analysis and study of the time trends over the last 20 years from a single center in India. J Family Med Prim Care. 2020;9:1695\u20139.","journal-title":"J Family Med Prim Care"},{"key":"1485_CR17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/SLA.0b013e3181f66596","volume":"253","author":"M van Heijl","year":"2011","unstructured":"van Heijl M, Omloo JM, van Berge Henegouwen MI, et al. Early response evaluation by PET during neoadjuvant chemoradiotherapy. Ann Surg. 2011;253:56\u201363.","journal-title":"Ann Surg"},{"issue":"12","key":"1485_CR18","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1200\/JCO.2001.19.12.3058","volume":"19","author":"WA Weber","year":"2001","unstructured":"Weber WA, Ott K, Becker K, et al. Prediction of response to preoperative chemotherapy in adenocarcinomas by metabolic imaging. J Clin Oncol. 2001;19(12):3058\u201365.","journal-title":"J Clin Oncol"},{"key":"1485_CR19","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1200\/JCO.2006.06.7801","volume":"24","author":"F Lordick","year":"2006","unstructured":"Lordick F, Ott K, Krause BJ, et al. PET to assess early metabolic response in esophageal adenocarcinoma. J Clin Oncol. 2006;24:4692\u20138.","journal-title":"J Clin Oncol"},{"key":"1485_CR20","doi-asserted-by":"publisher","first-page":"e42273","DOI":"10.1097\/MD.0000000000042273","volume":"104","author":"Q Wu","year":"2025","unstructured":"Wu Q, Li Q, Zhang R, Cui Y, Zou J, Zhang J, Ma C, Han D, Peng Y. Research progress of radiation esophagitis: A narrative review. Med (Baltim). 2025;104:e42273.","journal-title":"Med (Baltim)"},{"key":"1485_CR21","first-page":"119","volume":"7","author":"S Baker","year":"2016","unstructured":"Baker S, Fairchild A. Radiation-induced esophagitis in lung cancer. Lung Cancer (Auckl). 2016;7:119\u201328.","journal-title":"Lung Cancer (Auckl)"},{"issue":"5","key":"1485_CR22","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3109\/0284186X.2011.643822","volume":"51","author":"JT Kauppi","year":"2012","unstructured":"Kauppi JT, Oksala N, Salo JA, et al. Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy predicted by PET\/CT. Acta Oncol. 2012;51(5):636\u201344.","journal-title":"Acta Oncol"},{"issue":"2","key":"1485_CR23","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ijrobp.2011.12.029","volume":"84","author":"P Jayachandran","year":"2012","unstructured":"Jayachandran P, Pai RK, Quon A, et al. Postchemoradiotherapy PET predicts pathologic response and survival. Int J Radiat Oncol Biol Phys. 2012;84(2):471\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"29","key":"1485_CR24","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1200\/JCO.2006.06.7801","volume":"24","author":"K Ott","year":"2006","unstructured":"Ott K, Weber WA, Lordick F, et al. Metabolic imaging predicts response and survival in GEJ adenocarcinoma. J Clin Oncol. 2006;24(29):4692\u20138.","journal-title":"J Clin Oncol"},{"key":"1485_CR25","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.2967\/jnumed.118.224196","volume":"60","author":"MJ Valkema","year":"2019","unstructured":"Valkema MJ, Noordman BJ, Wijnhoven BPL, et al. Accuracy of \u00b9\u2078F-FDG PET\/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer. J Nucl Med. 2019;60:1553\u20139.","journal-title":"J Nucl Med"},{"key":"1485_CR26","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/bjs.10435","volume":"104","author":"JM Findlay","year":"2017","unstructured":"Findlay JM, Bradley KM, Wang LM, et al. Metabolic nodal response as prognostic marker after neoadjuvant therapy. Br J Surg. 2017;104:408\u201317.","journal-title":"Br J Surg"},{"key":"1485_CR27","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1080\/0284186X.2017.1328127","volume":"56","author":"G Papaxoinis","year":"2017","unstructured":"Papaxoinis G, Weaver JM, Khoja L, et al. FDG-avid regional lymph nodes in esophageal cancer. Acta Oncol. 2017;56:1224\u201330.","journal-title":"Acta Oncol"},{"key":"1485_CR28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/SLA.0000000000002830","volume":"271","author":"BJ Noordman","year":"2020","unstructured":"Noordman BJ, Shapiro J, Spaander MC, et al. Accuracy of detecting residual disease after CROSS neoadjuvant chemoradiotherapy for esophageal cancer (preSANO trial). Ann Surg. 2020;271:100\u20136.","journal-title":"Ann Surg"},{"key":"1485_CR29","first-page":"225","volume":"58","author":"PSN van Rossum","year":"2017","unstructured":"van Rossum PSN, Fried DV, Zhang L, et al. The value of \u00b9\u2078F-FDG PET before and after induction chemotherapy for the prediction of therapy response in esophageal cancer: a systematic review and meta-analysis. J Nucl Med. 2017;58:225\u201331.","journal-title":"J Nucl Med"},{"key":"1485_CR30","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00268-012-1470-y","volume":"36","author":"C Brown","year":"2012","unstructured":"Brown C, Howes B, Jamieson GG, et al. Accuracy of PET-CT in predicting survival in esophageal cancer. World J Surg. 2012;36:1089\u201395.","journal-title":"World J Surg"},{"issue":"3","key":"1485_CR31","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3390\/cancers12030607","volume":"12","author":"CH Lin","year":"2020","unstructured":"Lin CH, Hung TM, Chang YC, Hsieh CH, Shih MC, Huang SM, Yang CK, Chang CF, Chan SC, Yap WK. Prognostic Value of Lymph Node-To-Primary Tumor Standardized Uptake Value Ratio in Esophageal Squamous Cell Carcinoma Treated with Definitive Chemoradiotherapy. Cancers (Basel). 2020;12(3):607.","journal-title":"Cancers (Basel)"},{"key":"1485_CR32","doi-asserted-by":"crossref","unstructured":"Yap WK et al. Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiation. Eur J Nucl Med Mol Imaging. 2018;45:689\u2013698.","DOI":"10.1007\/s00259-017-3901-3"},{"issue":"8","key":"1485_CR33","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s12149-024-01933-5","volume":"38","author":"WK Yap","year":"2024","unstructured":"Yap WK, Hsu KH, Wang TH, Lin CH, Kang CJ, Huang SM, Lin HC, Hung TM, Chang KP, Tsai TY. The prognostic value of lymph node to primary tumor standardized uptake value ratio in cancer patients: a meta-analysis. Ann Nucl Med. 2024;38(8):607\u201318.","journal-title":"Ann Nucl Med"},{"issue":"8","key":"1485_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/dote\/dox021","volume":"30","author":"WK Yap","year":"2017","unstructured":"Yap WK, Chang YC, Tseng CK, Hsieh CH, Chao YK, Su PJ, Hou MM, Yang CK, Pai PC, Lin CR, Hsieh CE, Wu YY, Hung TM. Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer. Dis Esophagus. 2017;30(8):1\u201310.","journal-title":"Dis Esophagus"},{"key":"1485_CR35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/SLA.0000000000005788","volume":"278","author":"BJ van der Wilk","year":"2023","unstructured":"van der Wilk BJ, Eyck BM, Hofstetter WL, et al. ESOSTRATE: a multicenter randomized trial of esophagectomy versus active surveillance after neoadjuvant chemoradiotherapy in esophageal cancer. Ann Surg. 2023;278:31\u20139.","journal-title":"Ann Surg"},{"key":"1485_CR36","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1470-2045(25)00027-0","volume":"26","author":"BJ van der Wilk","year":"2025","unstructured":"van der Wilk BJ, Eyck BM, Wijnhoven BPL, et al. Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial. Lancet Oncol. 2025;26:425\u201336.","journal-title":"Lancet Oncol"},{"key":"1485_CR37","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1186\/s12967-024-05392-4","volume":"22","author":"L Fan","year":"2024","unstructured":"Fan L, Yang Z, Chang M, et al. CT-based delta-radiomics nomogram to predict pCR in ESCC. J Transl Med. 2024;22:579.","journal-title":"J Transl Med"},{"key":"1485_CR38","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s12029-024-01013-x","volume":"55","author":"AA Kaderi","year":"2024","unstructured":"Kaderi AA, Sabita J, Tiwari VK, et al. Treatment response in squamous esophageal cancer: metabolic vs. histopathology. J Gastrointest Canc. 2024;55:820\u20138.","journal-title":"J Gastrointest Canc"},{"key":"1485_CR39","first-page":"109567","volume":"182","author":"S Gupta","year":"2023","unstructured":"Gupta S, Sharma V, Jain A, et al. Radiomics-based prediction of pCR in neoadjuvant ESCC. Radiother Oncol. 2023;182:109567.","journal-title":"Radiother Oncol"},{"key":"1485_CR40","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1177\/0284185118791204","volume":"60","author":"S Gabrielson","year":"2019","unstructured":"Gabrielson S, Sanchez-Crespo A, Klevebro F, et al. \u00b9\u2078F-FDG PET\/CT after neoadjuvant treatment in esophageal cancer. Acta Radiol. 2019;60:578\u201385.","journal-title":"Acta Radiol"},{"key":"1485_CR41","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.3390\/biomedicines11113072","volume":"11","author":"WK Yap","year":"2023","unstructured":"Yap WK, Hsiao IT, Yap WL, Tsai TY, Lu YA, Yang CK, Peng MT, Su EL, Cheng SC. A Radiotherapy Dose Map-Guided Deep Learning Method for Predicting Pathological Complete Response in Esophageal Cancer Patients after Neoadjuvant Chemoradiotherapy Followed by Surgery. Biomedicines. 2023;11:3072.","journal-title":"Biomedicines"},{"key":"1485_CR42","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.3390\/biomedicines10112989","volume":"10","author":"WK Yap","year":"2022","unstructured":"Yap WK, Shih MC, Chang YC, Lin CH, Huang SM, Tsai TY, Chang CF, Hsu CC, Tseng CK, Chen MF, Tsan DL, Liau CT, Hou MM, Chao YK, Chiu CH, Hung TM. Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radiotherapy Era. Biomedicines. 2022;10:2989.","journal-title":"Biomedicines"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01485-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01485-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01485-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:02:04Z","timestamp":1779447724000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01485-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1485"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01485-z","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This was a retrospective study using anonymized\/de-identified clinical data; individual informed consent was waived by the Institutional Review Board\/Ethics Committee of the Cancer Institute (WIA), Chennai, India. All procedures were performed in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and Consent for Participation"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}